Loading company…
Nuwacell conducts iPSC research and develops cell therapies and clinical pipelines.
Established in 2016, Nuwacell focuses on iPSC technology, cell therapy, and clinical development for areas including tissue regeneration and cancer treatment. It serves hospitals, research organizations, and pharmaceutical companies. The company is based in Hefei, China, with a branch in Guangzhou. In November 2024, it raised CNY 235 million in Series B funding led by Guangzhou Kechuang Guofa Industry Fund Management; it raised further venture funding from Sfund in February 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in